Findings

What do systematic reviews say?

5 questions · 5 findings · 1 reviews · Musculoskeletal

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 2 · 40%Moderate 2 · 40%High 1 · 20%

Chondroitin with or without glucosamine vs placebo or control

Pain (short‐ and long‐term) Scale from 0 to 100 (lower is better) · patients with osteoarthritis

1 finding from 1 review

Chondroitin for osteoarthritis 2015 · Cochrane Headline outcomes only
no estimate extracted
22 studies · 3038 participants
Low

Chondroitin with or without glucosamine vs placebo or control

Physical function · patients with osteoarthritis

1 finding from 1 review

Chondroitin for osteoarthritis 2015 · Cochrane Headline outcomes only
no estimate extracted
5 studies · 1163 participants
Moderate

Chondroitin with or without glucosamine vs placebo or control

Composite Measure of Pain, Function and Disability as · patients with osteoarthritis

1 finding from 1 review

Chondroitin for osteoarthritis 2015 · Cochrane Headline outcomes only
no estimate extracted
16 studies · 2334 participants
Moderate

Chondroitin with or without glucosamine vs placebo or control

Pain (short‐ and long‐term) Scale from 0 to 100 mm (lower is better) · patients with osteoarthritis

1 finding from 1 review

Chondroitin for osteoarthritis 2015 · Cochrane Headline outcomes only
no estimate extracted
17 studies · 2262 participants
Low

Chondroitin with or without glucosamine vs placebo or control

WOMAC MCII Pain subscale (reduction in knee pain by 20%) ‐ Long‐term studies (≥ 6 months)—dose ≥ 800 mg/d · patients with osteoarthritis

Chondroitin with or without glucosamine leads to higher WOMAC MCII Pain subscale (reduction in knee pain by 20%) Long‐term… compared with placebo/control (high certainty).

1 finding from 1 review

Chondroitin for osteoarthritis 2015 · Cochrane Headline outcomes only
RR 1.12 [1.01, 1.24]
2 studies · 1253 participants
High